MAPT and Alzheimer disease: Though aluminium levels were found to be raised in AD hippocampus [29] and the metal ion was colocalized with NFTs and early tau deposits in brain sections [30,31], its relevance to AD pathogenesis is still unclear, especially due to the inconsistent outcome of epidemiological studies [32].